Conditions: Hepatic Impairment; Healthy Participants
Intervention: Drug: Linzagolix
Sponsor: ObsEva SA
Recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Safety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic Function
June 2, 2019ClinicalTrials.govComments OffHepatology(Liver, Pancreatic, Gall Bladder)Female | Function | Hepatic | Impaired | Linzagolix | Normal | Pharmacokinetics | Safety | Study | Subjects
Comments
